Evaluating Efficacy of a Chitosan Product Using a Double-Blinded, Placebo-Controlled Protocol

REFERENCES

• Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000.JAMA291 :238– 1245,2004 .
   Google Scholar
• Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States, 2000.JAMA293 :293– 294,2005 .
   PubMed Web of Science ®Google Scholar
• Vastag B: Obesity is now on everyone’s plate.JAMA291 :1186– 1188,2004 .
   PubMed Web of Science ®Google Scholar
• Associated Press: “Doctors Say They Must Model Healthy Diet,” June 15,2004 .
   Google Scholar
• Galuska DA, Will JC, Serdula MK, Ford ES: Are health care professionals advising obese patients to lose weight?JAMA282 :1576– 1578,1999 .
   PubMed Web of Science ®Google Scholar
• Wee CC, McCarthy EP, David RB, Phillips RS: Physician counseling about exercise.JAMA282 :1583– 1588,1999 .
   PubMed Web of Science ®Google Scholar
• Wang F, McDonald T, Champagne LJ, Edington DW: Relationship of body mass index and physical activity to health care costs among employees.J Occup Environ Med46 :428– 436,2004 .
   PubMed Web of Science ®Google Scholar
• Hennen WJ: Chitosan: the fiber that binds fat. In “Chitosan.” Pleasant Grove, UT: Woodland Publishing, pp3– 31,1996 .
   Google Scholar
• Furda I: Reduction of absorption of dietary lipids and cholesterol by chitosan and its derivatives and special formulations. In Muzzarelli RA (ed): “Chitosan per os: from Dietary Supplement to Drug Carrier,” Grottammare, Italy: Atec, pp65– 76,2000 .
   Google Scholar
• Kaats GR, Blum K, Pullin D, Keith SC, Wood R: A randomized double-masked placebo controlled replication and extension of the effects of chromium picolinate supplementation on body composition.Curr Ther Res Clin Exp59 :379– 388,1998 .
   Web of Science ®Google Scholar
• Schneider PL, Crouter SE, Bassett DR: Pedometer measures of free-living physical activity: comparison of 13 models.Med Sci Sports Exerc36 :331– 335,2004 .
   PubMed Web of Science ®Google Scholar
• The DIETCOACH, Nutritional Data Systems, Inc. New York, NY,1992 . (This company is no longer in business.)
   Google Scholar
• Muzzarelli RA, Tanfani F, Emanuelli M, Muzzarelli MG, Celia G: The production of chitosans of superior quality.J Appl Biochem3 :316– 321,1981 .
   Google Scholar
• Furda I, Brine CJ: Interaction of dietary fiber with lipids: mechanistic theories and their limitations.Adv Exp Med Biol270 :67– 82,1990 .
   PubMedGoogle Scholar
• Vahouny GV: Dietary fiber, lipid metabolism, and atherosclerosis.Fed Proc41 :2801– 2806,1982 .
   PubMedGoogle Scholar
• Kelsay JL, Behall KM, Prather ES: Effect of fiber from fruits and vegetables on metabolic responses of human subjects. I. Bowel transit time, number of defecations, fecal weight, urinary excretion of energy and nitrogen and apparent digestibilities of energy, nitrogen, and fat.Am J Clin Nutr31 :1149– 1153,1978 .
   PubMed Web of Science ®Google Scholar
• Anderson JW, Siesel AE: Hypocholesterolemic effects of oat products.Adv Exp Med Biol270 :17– 36,1990 .
   PubMedGoogle Scholar
• Krotkiewski M: Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects.Br J Nutr52 :97– 105,1984 .
   PubMed Web of Science ®Google Scholar
• Kay RM, Truswell AS: Effect of citrus pectin on blood lipids and fecal steroid excretion in man.Am J Clin Nutr30 :171– 175,1977 .
   PubMed Web of Science ®Google Scholar
• Trautwein EA, Kunath-Rau A, Erbersdobler HF: Increased fecal bile acid excretion and changes in the circulating bile acid pool are involved in the hypocholesterolemic and gallstone-preventative actions of psyllium in hamsters.J Nutr129 :896– 902,1999 .
   PubMed Web of Science ®Google Scholar
• Costa MA, Mehta T, Males JR: Effects of dietary cellulose, psyllium husk and cholesterol level on fecal and colonic microbial metabolism in monkeys.J Nutr119 :986– 992,1989 .
   PubMed Web of Science ®Google Scholar
• Ganji V, Kies CV: Psyllium husk fiber supplementation to soybean and coconut oil diets of humans: effect of fat digestibility and feacal fatty acid excretion.Eur J Clin Nutr48 :595– 597,1994 .
   PubMed Web of Science ®Google Scholar
• Haber GB, Heaton KW, Murphy D, Burroughs L: Depletion and disruption of dietary fibre: effects on satiety, plasma-glucose and serum-insulin.Lancet2 :679– 682,1977 .
   PubMed Web of Science ®Google Scholar
• Heaton KW: Food intake regulation and fiber. In Spiller GA, Kay RM, (eds): “Medical Aspects of Dietary Fiber.” New York: Plenum Medical, pp220– 238, 1980.
   Google Scholar
• Wadstein J, Thom E, Heldman E, Gudmundsson S, Lilja B: Biopolymer L112: a chitosan with fat binding properties and potential as a weight reducing agent. In Muzzarelli RA (ed): “Chitosan per os: from Dietary Supplement to Drug Carrier,” Grottammare, Italy: Atec, pp65– 76,2000 .
   Google Scholar
• Marcusen C, Preuss HG: Internal technical report for Richardson’s Labs. Boise, Iowa,1997 .
   Google Scholar
• Deuchi K, Kanauchi O, Imasato Y, Kobayashi E: Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet.Biosci Biotechnol Biochem59 :781– 785,1995 .
   PubMed Web of Science ®Google Scholar
• Kanauchi O, Deuchi K, Imasato Y, Kobayashi E: Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion.Biosci Biotechnol Biochem58 :1617– 1620,1994 .
   PubMed Web of Science ®Google Scholar
• Deuchi K, Kanauchi O, Imasato Y, Kobayashi E: Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high-fat diet.Biosci Biotechnol Biochem58 :1613– 1616,1994 .
   PubMed Web of Science ®Google Scholar
• Borroso Aranda J, Contreras F, Bagchi D, Preuss HG: Efficacy of a novel chitosan formulation on fecal fat excretion: a double-blind, crossover, placebo-controlled study.J Med33 :209– 225,2002 .
   PubMedGoogle Scholar
• Tsujikawa T, Kanauchi O, Andoh A, Saotome T, Sasaki M, Fujiyama Y, Bamba T: Supplement of a chitosan and ascorbic acid mixture for Crohn’s disease: a pilot study.Nutrition19 :137– 139,2003 .
   PubMed Web of Science ®Google Scholar
• Stern JS, Gades MD, Halsted CH: Chitosan does not block fat absorption in men fed high fat diet (Abstract). North American Association for Study of Obesity,1999 .
   Google Scholar
• Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R: Comparative evaluation of fecal fat excretion induced by orlistat and chitosan.Obes Res9 :364– 367,2001 .
   PubMedGoogle Scholar
• Heymsfield SB, Smith J, Kasriel S, Barlow J, Lynn MJ, Nixon D, Lawson DH: Energy malabsorption: measurement and nutritional consequences.Am J Clin Nutr34 :1954– 1960,1981 .
   PubMed Web of Science ®Google Scholar
• Blum JM: Executive Summary of Technical Report: Chitosol Triglyceride Testing. February2000 .
   Google Scholar
• Maezaki Y, Tsuji K, Nakagawa Y, Kawai Y, Akimoto M, Tsugita T, Takekawa T, Terada A, Hara H, Mitsuoka T: Hypocholesterolemic effect of chitosan in adult males.Biosci Biotechnol Biochem57 :1439– 1444,1993 .
   PubMed Web of Science ®Google Scholar
• Terada A, Hara H, Sato D, Higashi T, Nakayama S, Tsuji K, Sakamoto K, Ishioka E, Maezaki Y, Tsugita T, Takekawa T, Mitsuoka T: Metabolites of humans.Microb Ecol Health Dis8 :15– 21,1995 .
   Web of Science ®Google Scholar
• Angerer JD, Cykron DM, Iyer S, Jerrell TA: Dry acid-chitosan complexes, patent 6,326,475, December 4,2001 .
   Google Scholar
• Bailly J, Fleury A, Hadvary P, Lengfeld H, Steffan H: Pharmaceutical composition containing chitosan, patent 6,030,953, Feb 29,2000 .
   Google Scholar
• Isler D, Rehm W, Widmer E: Biomasses to treat non-human animals. Patent 5,447,953, September 5,1995 .
   Google Scholar
• Gondal JA, MacArthy P, Myers AK, Preuss HG: Effects of dietary sucrose and fibers on blood pressure in hypertensive rats.Clin Nephrol45 :163– 168,1996 .
   PubMed Web of Science ®Google Scholar
• Miura T, Usami M, Tsuura Y, Ishida H, Seino Y: Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice.Biol Pharm Bull18 :1623– 1625,1995 .
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.Diabetes Care14 :173– 194,1991 .
   PubMed Web of Science ®Google Scholar
• Preuss HG: Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.J Am Coll Nutr16 :397– 403,1997 .
   PubMed Web of Science ®Google Scholar
• Crawford V, Scheckenbach R, Preuss HG: Effects of niacin-bound chromium supplementation on body composition in overweight African-American women.Diabetes Obes Metab1 :331– 337,1999 .
   PubMed Web of Science ®Google Scholar